Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2017 1
2019 2
2020 1
2021 2
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Automated, scaled, transposon-based production of CAR T cells.
Lock D, Monjezi R, Brandes C, Bates S, Lennartz S, Teppert K, Gehrke L, Karasakalidou-Seidt R, Lukic T, Schmeer M, Schleef M, Werchau N, Eyrich M, Assenmacher M, Kaiser A, Prommersberger S, Schaser T, Hudecek M. Lock D, et al. Among authors: schaser t. J Immunother Cancer. 2022 Sep;10(9):e005189. doi: 10.1136/jitc-2022-005189. J Immunother Cancer. 2022. PMID: 36096530 Free PMC article.
Automated generation of gene-edited CAR T cells at clinical scale.
Alzubi J, Lock D, Rhiel M, Schmitz S, Wild S, Mussolino C, Hildenbeutel M, Brandes C, Rositzka J, Lennartz S, Haas SA, Chmielewski KO, Schaser T, Kaiser A, Cathomen T, Cornu TI. Alzubi J, et al. Among authors: schaser t. Mol Ther Methods Clin Dev. 2020 Dec 25;20:379-388. doi: 10.1016/j.omtm.2020.12.008. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2020. PMID: 33575430 Free PMC article.
Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma.
Teppert K, Winter N, Herbel V, Brandes C, Lennartz S, Engert F, Kaiser A, Schaser T, Lock D. Teppert K, et al. Among authors: schaser t. Front Immunol. 2023 Oct 11;14:1178060. doi: 10.3389/fimmu.2023.1178060. eCollection 2023. Front Immunol. 2023. PMID: 37901209 Free PMC article.
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells.
Werchau N, Kotter B, Criado-Moronati E, Gosselink A, Cordes N, Lock D, Lennartz S, Kolbe C, Winter N, Teppert K, Engert F, Webster B, Mittelstaet J, Schaefer D, Mallmann P, Mallmann MR, Ratiu D, Assenmacher M, Schaser T, von Bergwelt-Baildon M, Abramowski P, Kaiser AD. Werchau N, et al. Among authors: schaser t. Oncoimmunology. 2022 Nov 11;11(1):2140534. doi: 10.1080/2162402X.2022.2140534. eCollection 2022. Oncoimmunology. 2022. PMID: 36387056 Free PMC article.
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy.
Yonezawa Ogusuku IE, Herbel V, Lennartz S, Brandes C, Argiro E, Fabian C, Hauck C, Hoogstraten C, Veld S, Hageman L, Teppert K, Koutsoumpli G, Griffioen M, Mockel-Tenbrinck N, Schaser T, de Groot R, Johnston ICD, Lock D. Yonezawa Ogusuku IE, et al. Among authors: schaser t. Mol Ther Methods Clin Dev. 2024 Feb 27;32(2):101224. doi: 10.1016/j.omtm.2024.101224. eCollection 2024 Jun 13. Mol Ther Methods Clin Dev. 2024. PMID: 38516690 Free PMC article.
CAR'TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment.
Teppert K, Yonezawa Ogusuku IE, Brandes C, Herbel V, Winter N, Werchau N, Khorkova S, Wöhle C, Jelveh N, Bisdorf K, Engels B, Schaser T, Anders K, Künkele A, Lock D. Teppert K, et al. Among authors: schaser t. Mol Ther Oncol. 2024 Mar 22;32(2):200797. doi: 10.1016/j.omton.2024.200797. eCollection 2024 Jun 20. Mol Ther Oncol. 2024. PMID: 38601972 Free PMC article.
15 results